Northwestern Mutual Wealth Management
TRAW icon

Northwestern Mutual Wealth Management’s Traws Pharma TRAW Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio TRAW Stock Details TRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4 Buy
+2
New +$4 ﹤0.01% 4096
2022
Q3 		– Sell
-1
Closed – – 3440
2022
Q2 		$0 Buy
+1
New +$34 ﹤0.01% 3519

Other funds holding TRAW

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $273M AUM
DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PWM
Palumbo Wealth Management Great Neck, New York $410M AUM 32.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Northwestern Mutual Wealth Management's TRAW Position: Q1 2026 in Review

Northwestern Mutual Wealth Management opened a new position in Traws Pharma (TRAW) in Q1 2026: 2 shares worth $4. The stake represents ﹤0.01% of the portfolio and ranks #4096 among its holdings. This is a return to the name: Northwestern Mutual Wealth Management previously reported a position in TRAW as recently as Q2 2022.

Northwestern Mutual Wealth Management first reported a position in TRAW in Q2 2022 and has held it in 2 quarters since. 28 funds tracked by Wall St. Rank hold TRAW as of Q1 2026.

  • Northwestern Mutual Wealth Management held 2 shares of Traws Pharma worth $4 as of Q1 2026.
  • Traws Pharma was a new Northwestern Mutual Wealth Management position in Q1 2026.
  • Traws Pharma made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q1 2026, its #4096 holding.
  • Northwestern Mutual Wealth Management first reported a position in Traws Pharma in Q2 2022 and has held it in 2 quarters since.
  • 28 funds tracked by Wall St. Rank held Traws Pharma as of Q1 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.